Astaxanthin inhibits microglia M1 activation against inflammatory injury triggered by lipopolysaccharide through

Xin Zhou1, Junyu Zhang2, Yuxin Li2

  • 1The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang 524023, China; Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang), Zhanjiang 524023, China; The Marine Biomedical Research Institute of Guangdong Zhanjiang, Zhanjiang 524023, China.

Life Sciences
|December 28, 2020
PubMed
Abstract

Insights

Astaxanthin inhibits neuroinflammation by down-regulating miR-31-5p, suppressing microglia M1 activation. This natural carotenoid shows potential for treating neuroinflammatory conditions.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Astaxanthin, a natural carotenoid, possesses neuroprotective properties and can cross the blood-brain barrier.
  • Microglia M1 activation is a key process in neuroinflammation.

Purpose of the Study:

  • To investigate the molecular mechanisms by which Astaxanthin inhibits microglia M1 activation.
  • To explore the role of miR-31-5p in Astaxanthin's neuroprotective effects.

Main Methods:

  • Experiments were conducted on BV2 cells and mice pre-treated with Astaxanthin and stimulated with Lipopolysaccharide (LPS).
  • Gene and protein expression of M1-related factors and Notch pathway molecules were analyzed using RT-qPCR, western blot, and immunofluorescence.
  • Luciferase activity assays were used to confirm the target association between miR-31-5p and Numb.

Main Results:

  • Astaxanthin inhibited LPS-induced M1-related factor expression in BV2 cells and reduced M1 markers in the hippocampus of LPS-treated mice.
  • Astaxanthin's suppression of M1 factors was reversed by miR-31-5p mimic, indicating miR-31-5p's role in the mechanism.
  • Astaxanthin downregulated Notch pathway components (Notch1, Hes1, Hes5) and increased Numb expression, effects reversed by miR-31-5p mimic.

Conclusions:

  • Astaxanthin suppresses neuroinflammation by down-regulating miR-31-5p, thereby inhibiting microglia M1 activation.
  • Targeting miR-31-5p with Astaxanthin presents a potential therapeutic strategy for neuroinflammatory diseases.

Related Concept Videos